Previously in this series, we saw how Frontline (FRO) fared in 3Q17. In this part, we’ll see how analysts revised Frontline’s target price. We’ll also discuss analysts’ consensus recommendations for Frontline and its peers.
Interested in FRO?
				Don't miss the next report.
			
				Receive e-mail alerts for new research on FRO

Success! 
			You are now receiving e-mail alerts for new  research. A temporary password for your new Market Realist account has been sent to your e-mail address.
		
Success! 
 has been added to your Ticker Alerts.
		
Success! 
 has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.
		On November 24, 2017, Morgan Stanley reduced Frontline’s target price to $5 from $5.5. On November 22, 2017, Evercore reduced Frontline’s target price to $4.5 from $5 and maintained an “underperform” rating.Five analysts gave recommendations on Frontline. According to Reuters, the consensus rating for the stock is 3, which means a “hold.” Out of the five analysts, none of the analysts gave a “strong buy” recommendation. One analyst gave a “buy” recommendation, three analysts gave “hold” recommendations, and the remaining analyst recommended a “sell.”The consensus 12-month target price for Frontline is $5.9. Compared to the current market price of $5.45 on September 27, 2017, the target price implies a potential upside of 8.3%.Quote data by Xignite